After GCPGC administration , 4 different pharmacokinetic phases were identified , indicating target-mediated drug disposition ( TMDD ) for the elimination of GCPGC , which was slowed down as the dose was increased , resulting in a higher than proportional dose-normalized exposure to GCPGC .